Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer.

Fransson, Åsa; Glaessgen, Daria; Alfredsson, Jessica; Wiman, Klas G; Bajalica-Lagercrantz, Svetlana; Mohell, Nina.
J Ovarian Res; 9(1): 27, 2016 May 14.
Artigo em Inglês | MEDLINE | ID: mdl-27179933